Over the past two years, Novo Nordisk (NYSE: NVO) has lost its lead in the anti-obesity space to its biggest competitor, Eli ...
Ultherapy PRIME elegantly celebrates its 1st anniversary, reinforcing its position as the number one Gold Standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results